Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Seven-Year Microbiological and Molecular Study of Bacteremias Due to Carbapenemase-Producing Klebsiella Pneumoniae: An Interrupted Time-Series Analysis of Changes in the Carbapenemase Gene's Distribution after Introduction of Ceftazidime/Avibactam.
Papadimitriou-Olivgeris M, Bartzavali C, Karachalias E, Spiliopoulou A, Tsiata E, Siakallis G, Assimakopoulos SF, Kolonitsiou F, Marangos M. Papadimitriou-Olivgeris M, et al. Among authors: tsiata e. Antibiotics (Basel). 2022 Oct 14;11(10):1414. doi: 10.3390/antibiotics11101414. Antibiotics (Basel). 2022. PMID: 36290072 Free PMC article.
Reversal of carbapenemase-producing Klebsiella pneumoniae epidemiology from blaKPC- to blaVIM-harbouring isolates in a Greek ICU after introduction of ceftazidime/avibactam.
Papadimitriou-Olivgeris M, Bartzavali C, Lambropoulou A, Solomou A, Tsiata E, Anastassiou ED, Fligou F, Marangos M, Spiliopoulou I, Christofidou M. Papadimitriou-Olivgeris M, et al. Among authors: tsiata e. J Antimicrob Chemother. 2019 Jul 1;74(7):2051-2054. doi: 10.1093/jac/dkz125. J Antimicrob Chemother. 2019. PMID: 31002313
Improvement of Chemotherapy Solutions Production Procedure in a Hospital Central Chemotherapy Preparation Unit: A Systematic Risk Assessment to Prevent Avoidable Harm in Cancer Patients.
Bourika K, Koutras A, Kalofonos H, Vicha A, Tsiata E, Papadimitriou E, Avgoustakis K, Panagi Z. Bourika K, et al. Among authors: tsiata e. Clin Med Insights Oncol. 2019 Jun 10;13:1179554919852933. doi: 10.1177/1179554919852933. eCollection 2019. Clin Med Insights Oncol. 2019. PMID: 31217699 Free PMC article.
Phase II study of irinotecan plus leucovorin and bolus 5-fluorouracil as first- or second-line chemotherapy in patients with advanced gastric or esophageal-gastric junction adenocarcinoma.
Koutras AK, Gerolymos MK, Kontogeorgou E, Iconomou G, Vourli G, Tsiata E, Makatsoris T, Chrysanthopoulos C, Kalofonos HP. Koutras AK, et al. Among authors: tsiata e. J Chemother. 2007 Dec;19(6):724-30. doi: 10.1179/joc.2007.19.6.724. J Chemother. 2007. PMID: 18230557 Clinical Trial.
11 results